STAT December 10, 2024
Mario Aguilar

Koneksa’s pitch shows why some digital health startups are at the mercy of drug developers

NEW YORK — On the 77th floor of One World Trade Center, in an office with panoramic views of Manhattan, executives from pharma and biotech companies like Regeneron and Merck heard the pitch: Please help us study GLP-1s in Parkinson’s disease.

With the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
How has U.S. Spending on Health Care Changed Over Time?
Merck enters $2B licensing deal for weight loss drug
How Medicare Negotiated Drug Prices Compare to Other Countries
The Fed's Warnings On Inflation Are Bad News For Biotech Startups
AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More

Share This Article